Genomic Life
Genomic Life is a private, U.S.-based healthcare navigation company that sells genetics-based screening (cancer, heart, pharmacogenomic, and carrier) plus ongoing navigator and genetic counselor support, delivered as an employer-sponsored benefit or direct membership subscription.
- Company typePrivate
- Founded2017
- HeadquartersLa Jolla, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Genomic Life does
Genomic Life, Inc. is a Delaware-incorporated, privately held genetics-based healthcare navigation company headquartered in San Diego/La Jolla, California, founded in 2017 and operating with 51–100 employees. The company delivers a membership-based platform combining medical-grade DNA screening — Genetic Health Screen (covering 100+ conditions), Pharmacogenomic Testing (PGx), and Carrier Screening — with ongoing personalized guidance from human navigators and Board-certified genetic counselors, plus a dedicated Cancer Navigation program for members facing a cancer diagnosis. All services are coordinated through a HIPAA-compliant, HITRUST r2 / SOC 2 Type 2 / NIST CSF-certified member portal.
The company operates two go-to-market motions. The primary channel is B2B2C: employers and benefits brokers purchase Genomic Life as an employee benefit, with coverage terms set in per-employer Master Services Agreements and annual billing cycles. A secondary Direct Membership channel allows U.S. residents to self-enroll for a 12-month minimum commitment, billed annually. Distribution and customer success are staffed by dedicated Sales, Client Management, and Navigation Services teams. Geographic scope is United States only.
The business model is subscription/recurring revenue, with pricing negotiated per employer contract and not publicly disclosed. The most recent disclosed capital activity is a 2024 exempt securities offering under SEC Rule 506(b) — a $15 million total offering of which $10 million had been sold as of May 2024, with Casdin Capital identified as a participating investor and Farmington Capital Partners from an earlier 2017 relationship. Program-level outcome data published by the company reports that 18.5% of 5,000+ screened individuals (Jan 2023 – Jul 2024) were identified with elevated genetic risk, and externally cited studies indicate 87% of genetically identified disease had not been previously diagnosed.
Genomic Life firmographics
Firmographics- Name
- Genomic Life
- Legal name
- Genomic Life, Inc.
- Website
- https://genomiclife.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Genomic Life is a private, U.S.-based healthcare navigation company that sells genetics-based screening (cancer, heart, pharmacogenomic, and carrier) plus ongoing navigator and genetic counselor support, delivered as an employer-sponsored benefit or direct membership subscription.
- Ownership category
- akta.pro rank
Genomic Life industry classification
Industry- Product category
- Genetic Testing and Healthcare Navigation Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Population Genomics & Preventive Precision Health Programs (HLAAANAL)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Pharmacogenomics-Informed Medication Optimization Support (HSABALAO)
Keywords
Where Genomic Life is headquartered
LocationHeadquarters
- HQ city
- La Jolla
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Genomic Life business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Employer-Sponsored Membership: Genomic Life offers employer-provided benefit memberships where employers pay for employee access to the genetic screening program. Coverage begins when employer determines eligibility.
- Direct Membership: Individual self-pay memberships with a minimum 12-month commitment, billed annually. Members receive DNA screenings, personalized guidance, and cancer navigation services.
- Equity Financing: The company raised capital through exempt securities offerings under Rule 506(b) of Regulation D, with a $15 million offering.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Employer-Offered Benefit Membership |
| Subscription | Annual | Direct Membership |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Genomic Life product offering
Product offeringCore offering
Genomic Life sells a genetics-based healthcare navigation membership that combines medical-grade DNA screenings (Genetic Health Screen, Pharmacogenomic Testing, Carrier Screening) with personalized guidance from trained navigators and Board-certified genetic counselors, plus dedicated cancer navigation services. The membership is delivered either as an employer-sponsored employee benefit or as a Direct Membership for self-pay individuals, all coordinated through a HIPAA-compliant member portal.
Product overview
Genomic Life offers a genetics-based healthcare navigation platform delivered as a unified membership program combining three core components: DNA-based genetic screenings (Genetic Health Screen, Pharmacogenomic Testing, and Carrier Screening), personalized health guidance from expert navigators and genetic counselors, and dedicated cancer navigation services for members affected by cancer. The company operates two membership models: Direct Membership (self-pay) and Employer-Offered Benefit Membership (B2B). All services are coordinated through a secure member portal (member.genomiclife.com) with no additional fees beyond membership.
Differentiator
Problem solved
Functional benefit
Products and services
- Genetic Health Screen Medical-grade DNA screening test that identifies actionable genetic risks for over 100 conditions (including breast, colon, ovarian, pancreatic, and prostate cancer; aortopathies, arrhythmias, cardiomyopathies, and genetic high cholesterol) for members and employer populations, with results delivered through a secure member portal supported by navigators and genetic counselors.
- Pharmacogenomic Testing (PGx) DNA test that profiles how an individual's genetic makeup affects response to medications, enabling care teams to optimize prescriptions across mental health, bleeding/clotting disorders, stomach acid, pain management, and high cholesterol, with the goal of reducing adverse drug reactions and trial-and-error prescribing.
- Carrier Screening Genetic test for prospective parents that assesses the risk of transmitting heritable genetic disorders to children, recommended by ACOG for all pregnant women and those planning pregnancy, and most informative when both reproductive partners are tested.
- Cancer Navigation Dedicated oncology navigator support program for members facing a cancer diagnosis, providing access to genomics-based solutions, peer-to-peer consults, expert cancer care resources, and personalized care coordination throughout every stage of cancer (current or historical).
- Direct Membership Self-pay membership for U.S. residents that bundles DNA screenings (Genetic Health Screen, PGx, Carrier Screening), personalized health guidance from navigators and genetic counselors, and cancer navigation services, with a 12-month minimum commitment, annual billing, and a 72-hour cancellation refund window.
- Employer-Offered Benefit Membership Employer-sponsored benefit membership that provides DNA screenings, personalized health guidance, and cancer navigation services to eligible employees and their families, with eligibility and fees defined in a Master Services Agreement and Scope of Work between Genomic Life and the employer.
Quantifiable outcome
- 18.5% of individuals screened were identified with elevated health risks (cancer 5.5%, heart/bleeding disorders 10.3%, other conditions 2.7%)
- +4 more outcomes
Companies that use Genomic Life
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Genomic Life technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Genomic Life partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Partner LaboratoriescoreGenomic Life partners with top clinical genetic laboratories for DNA sample processing. These partner laboratories follow the highest standards of privacy and security, are HIPAA-covered entities, and Genomic Life negotiates Business Associate Agreements (BAAs) with each.
- Precision Medicine ProviderscoreThe company curates options from top precision medicine providers to offer access to the highest quality services for organizations and individuals. They provide service redundancy and adaptability to market changes.
- Healthcare ProviderscoreGenomic Life discloses limited personal information to healthcare providers, care teams, and clinical service providers as reasonably necessary to provide, coordinate, support, or facilitate member services.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Genomic Life competitors and assessment
Company assessmentBroad incumbents
- Invitae:
- 23andMe: 23andMe is a broad incumbent in consumer genetic testing with a large DTC installed base and a health + ancestry product portfolio. It is comparable on genetic screening technology and consumer brand awareness but does not focus on employer-sponsored navigation as its primary channel.
- Natera: Natera is a publicly-traded clinical genetic testing company with a broad portfolio spanning reproductive, oncology, and organ health. It is comparable on clinical-grade genetic testing infrastructure and enterprise sales motion, but operates primarily through providers and payers rather than employer benefit channels.
Direct peers
- Color Health: Color Health is the closest direct peer, offering population-scale genetic screening and cancer navigation delivered as an employer and health plan benefit. Both companies sell genetic health programs to employer populations with a navigation layer, target the same buyers (HR leaders, benefits brokers), and compete head-to-head on the B2B2C genomics benefit category.
- Genome Medical: Genome Medical provides genetic counseling and clinical genomics services delivered virtually, with employer and health system channels. It is directly comparable to Genomic Life's navigator-led model and genetic counselor support, though it focuses more on clinical delivery than direct DNA screening.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Genomic Life social profiles
Digital presenceGenomic Life compliance and trust
Trust signalCompliance4 records
Genomic Life financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genomic Life leadership team
Management profileNumber of profiles
Profiles6 records
Genomic Life funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genomic Life M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genomic Life
What does Genomic Life do?
Genomic Life sells a genetics-based healthcare navigation membership that combines medical-grade DNA screenings (Genetic Health Screen, Pharmacogenomic Testing, Carrier Screening) with personalized guidance from trained navigators and Board-certified genetic counselors, plus dedicated cancer navigation services. The membership is delivered either as an employer-sponsored employee benefit or as a Direct Membership for self-pay individuals, all coordinated through a HIPAA-compliant member portal.
Is Genomic Life a public or private company?
Genomic Life is a private company. It is classified as venture growth investor backed and is currently operating.
When was Genomic Life founded?
Genomic Life was founded in 2017. It employs 51 to 100 people.
Where is Genomic Life based?
Genomic Life is headquartered in La Jolla, United States, in the North America region.
How does Genomic Life make money?
Three revenue lines are on record. Employer-Sponsored Membership is the primary driver. The others are direct Membership and equity Financing.
Who are Genomic Life's main competitors?
Broad incumbents on record are Invitae, 23andMe and Natera. Direct peers are Color Health and Genome Medical.
Does Genomic Life have an API?
No public API is recorded for Genomic Life.
What industry is Genomic Life in?
Genomic Life's product category is Genetic Testing and Healthcare Navigation Services. Its primary akta.pro industry code is HLAAANAL, Population Genomics & Preventive Precision Health Programs, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8000.